Calvert E L, Whorwell P J, Houghton L A
Academic Department of Medicine, University Hospital of South Manchester, Manchester, UK.
Aliment Pharmacol Ther. 2004 Apr 1;19(7):805-15. doi: 10.1111/j.1365-2036.2004.01901.x.
Little is known about the effect of 5-hydroxytryptamine 1 (5-HT(1)) receptor agonism on the co-ordinated motor activity of the gastric antrum, pylorus and duodenum under fasting and fed conditions.
To evaluate the effect of sumatriptan, a 5-HT(1) agonist, on fasting and fed antro-pyloro-duodenal motility.
In study 1, antro-pyloro-duodenal motility was recorded for two phase IIIs of the migrating motor complex and then, following either a subcutaneous injection of sumatriptan 6 mg or saline control, for at least one additional phase III in 11 healthy volunteers (21-36 years). In study 2, the post-prandial motility was recorded for 3 h after either a subcutaneous injection of sumatriptan 6 mg or saline control in 10 healthy volunteers (18-36 years).
Sumatriptan prolonged the migrating motor complex cycle (P = 0.009) by increasing the duration of phase II (P = 0.02) but not phases I and III. Post-prandially, sumatriptan reduced the activity index (P = 0.017) by reducing the frequency of co-ordinated motor activity involving the antrum and/or the duodenum (P < 0.05).
5-HT(1) receptor agonism increases the periodicity of the migrating motor complex and reduces the occurrence of post-prandial co-ordinated motor activity involving the gastric antrum, pylorus and duodenum.
关于5-羟色胺1(5-HT(1))受体激动作用在禁食和进食条件下对胃窦、幽门和十二指肠协调运动活性的影响,人们了解甚少。
评估5-HT(1)激动剂舒马曲坦对禁食和进食状态下胃窦-幽门-十二指肠运动的影响。
在研究1中,记录11名健康志愿者(21 - 36岁)移行运动复合波两个III期的胃窦-幽门-十二指肠运动,然后皮下注射6毫克舒马曲坦或生理盐水对照,之后至少再记录一个III期。在研究2中,记录10名健康志愿者(18 - 36岁)皮下注射6毫克舒马曲坦或生理盐水对照后3小时的餐后运动。
舒马曲坦通过延长II期持续时间(P = 0.02)而不是I期和III期,延长了移行运动复合波周期(P = 0.009)。餐后,舒马曲坦通过降低涉及胃窦和/或十二指肠的协调运动频率(P < 0.05),降低了活动指数(P = 0.017)。
5-HT(1)受体激动作用增加了移行运动复合波的周期性,并减少了餐后涉及胃窦、幽门和十二指肠的协调运动的发生。